An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The solute carrier (SLC) superfamily represents the biggest family of transporters with important roles in health and disease. Despite being attractive and druggable targets, the majority of SLCs remains understudied. One major hurdle in research on SLCs is the lack of tools, such as cell-based assays to investigate their biological role and for drug discovery. Another challenge is the disperse and anecdotal information on assay strategies that are suitable for SLCs. This review provides a comprehensive overview of state-of-the-art cellular assay technologies for SLC research and discusses relevant SLC characteristics enabling the choice of an optimal assay technology. The Innovative Medicines Initiative consortium RESOLUTE intends to accelerate research on SLCs by providing the scientific community with high-quality reagents, assay technologies and data sets, and to ultimately unlock SLCs for drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847 · cited 1×
“HTP assays typically implement simple protocols and their quality is primarily determined based on the Z’ factor, which quantifies the assay window (Zhang et al., 1999).”
BackgroundUniProt: the universal protein knowledgebase in 2021
The UniProt Consortium, Bateman, A., Martin, M.-J., Orchard, S., Magrane, M., Agivetova, R., Ahmad, S., Alpi, E., Bowler-Barnett, E. H., Britto, R., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1100 · Cited by 6,372 · cited 2×
“, 2021), or according to the description in Uniprot (Bateman et al., 2021).”
BackgroundThe Gene Ontology resource: enriching a GOld mine
The Gene Ontology Consortium, Carbon, S., Douglass, E., Good, B. M., Unni, D. R., Harris, N. L., Mungall, C. J., Basu, S., Chisholm, R. L., Dodson, R. J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1113 · Cited by 3,555 · cited 2×
“, 2020) or the Gene Ontology (Ashburner et al., 2000; Carbon et al., 2021), or according to the description in Uniprot (Bateman et al.”
BackgroundMembrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
The Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294 · cited 2×
“Untargeted MS following methodologies and guidelines in (Brown et al., 2005; Broadhurst and Kell, 2007; Dunn et al., 2011; Mullard et al., 2015; Broadhurst et al., 2018) enable the measurement of differences in the uptake of a broad range and number (thousands) of compounds by cell lines (Wright Muelas et al.”
BackgroundMethodSelf-citationMonitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Baculovirus as versatile vectors for protein expression in insect and mammalian cells
Kost, T. A., Condreay, J. P., & Jarvis, D. L. (2005) · Nature Biotechnology · doi:10.1038/nbt1095 · Cited by 1,014
Sun, F., Zeng, J., Jing, M., Zhou, J., Feng, J., Owen, S. F., Luo, Y., Li, F., Wang, H., Yamaguchi, T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.042 · Cited by 837
Crystal structure of the human glucose transporter GLUT1
Deng, D., Xu, C., Sun, P., Wu, J., Yan, C., Hu, M., & Yan, N. (2014) · Nature · doi:10.1038/nature13306 · Cited by 777 · cited 1×
“, 2019)) families adopt a LeuT fold, while members of SLC2 (SLC2A1/GLUT1 (Deng et al., 2014)) and SLC16 (SLC16A7/MCT2 (Zhang B.”
BackgroundSLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1
Rebsamen, M., Pochini, L., Stasyk, T., de Araújo, M. E. G., Galluccio, M., Kandasamy, R. K., Snijder, B., Fauster, A., Rudashevskaya, E. L., Bruckner, M., et al. (2015) · Nature · doi:10.1038/nature14107 · Cited by 673 · cited 1×
“, 2018), amino acids sensing (Rebsamen et al., 2015; Wang et al., 2015), metal sensing (Zhang C.”
BackgroundSelf-citationA genetically encoded fluorescent sensor for rapid and specific in vivo detection of norepinephrine
Feng, J., Zhang, C., Lischinsky, J. E., Jing, M., Zhou, J., Wang, H., Zhang, Y., Dong, A., Wu, Z., Wu, H., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.037 · Cited by 545
Amino acid transporters revisited: New views in health and disease
Kandasamy, P., Gyimesi, G., Kanai, Y., & Hediger, M. A. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.05.003 · Cited by 484 · cited 1×
“For example, some 60 SLCs are thought to be competent for the transport of the 21 proteogenic amino acids (Kandasamy et al., 2018), of which approximately half is capable of shuttling glutamine (Meixner et al.”
BackgroundCarrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Dobson, P. D., & Kell, D. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2438 · Cited by 475 · cited 1×
“In addition, increasing amount of evidence suggests that most drugs and steroid hormones may require transporters to enter cells (Dobson and Kell, 2008; Okamoto et al., 2018; Girardi et al., 2020a).”
BackgroundSelf-citationYoo, H. C., Park, S. J., Nam, M., Kang, J., Kim, K., Yeo, J. H., Kim, J.-K., Heo, Y., Lee, H. S., Lee, M. Y., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.020 · Cited by 449 · cited 2×
“Some SLCs transport molecules only across the membranes of intracellular compartments, like the SLC25 family expressed on the mitochondrial membranes, while others are not restricted to only one organelle, such as SLCs with multiple isoforms, which are expressed in different organelles (Mazurek et al., 2010; Yoo et al…”
BackgroundLigand and Target Discovery by Fragment-Based Screening in Human Cells
Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., et al. (2017) · Cell · doi:10.1016/j.cell.2016.12.029 · Cited by 439
Minireview: Thyroid Hormone Transporters: The Knowns and the Unknowns
Visser, W. E., Friesema, E. C. H., & Visser, T. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0095 · Cited by 390 · cited 1×
“Thyroid hormone transporters like SLC16A2 and SLC16A10 might also be amenable for this assay type (Visser et al., 2011).”
BackgroundStructure of the human LAT1–4F2hc heteromeric amino acid transporter complex
Yan, R., Zhao, X., Lei, J., & Zhou, Q. (2019) · Nature · doi:10.1038/s41586-019-1011-z · Cited by 358
Forbes, J. R., & Gros, P. (2003) · Blood · doi:10.1182/blood-2003-02-0425 · Cited by 288
Unifying principles of bifunctional, proximity-inducing small molecules
Gerry, C. J., & Schreiber, S. L. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0469-1 · Cited by 199 · cited 1×
“These could be further developed as chemical modulators of function, as corrector, potentiator, stabilizer or degrader depending on the target SLC (Gerry and Schreiber, 2020; Lopes-Pacheco, 2020).”
BackgroundThe solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
Winter, G. E., Radic, B., Mayor-Ruiz, C., Blomen, V. A., Trefzer, C., Kandasamy, R. K., Huber, K. V. M., Gridling, M., Chen, D., Klampfl, T., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1590 · Cited by 175 · cited 1×
“In addition, membrane transporters may influence the pharmacokinetic profile of a drug, and mutation or downregulation of a transporter may lead to development of resistance and treatment failure (Winter et al., 2014).”
BackgroundSelf-citationA Membrane Transporter Is Required for Steroid Hormone Uptake in Drosophila
Okamoto, N., Viswanatha, R., Bittar, R., Li, Z., Haga-Yamanaka, S., Perrimon, N., & Yamanaka, N. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.09.012 · Cited by 144
Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer
McMillan, E. A., Ryu, M.-J., Diep, C. H., Mendiratta, S., Clemenceau, J. R., Vaden, R. M., Kim, J.-H., Motoyaji, T., Covington, K. R., Peyton, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.028 · Cited by 141 · cited 2×
“Although to our knowledge only few other studies use the cellular TSA to target SLCs, namely SLC2 family (McMillan et al., 2018; Reckzeh et al., 2019), a number of studies have applied the cellular TSA for transmembrane proteins (Huber et al.”
BackgroundGlutamate Clearance Is Locally Modulated by Presynaptic Neuronal Activity in the Cerebral Cortex
Armbruster, M., Hanson, E., & Dulla, C. G. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2066-16.2016 · Cited by 131
MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2
Coady, M. J., El Tarazi, A., Santer, R., Bissonnette, P., Sasseville, L. J., Calado, J., Lussier, Y., Dumayne, C., Bichet, D. G., & Lapointe, J.-Y. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111282 · Cited by 106 · cited 2×
“, 2014), or MAP17 regulating SLC5A2 (Coady et al., 2017).”
Bensimon, A., Pizzagalli, M. D., Kartnig, F., Dvorak, V., Essletzbichler, P., Winter, G. E., & Superti-Furga, G. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.04.003 · Cited by 102 · cited 1×
“Hence short-term perturbations, such as inducible systems, selective inhibitors or targeted protein degradation, may be advantageous (Bensimon et al., 2020; Wu et al., 2020).”
BackgroundSelf-citationThe yeast mitochondrial pyruvate carrier is a hetero-dimer in its functional state
Tavoulari, S., Thangaratnarajah, C., Mavridou, V., Harbour, M. E., Martinou, J., & Kunji, E. R. (2019) · The EMBO Journal · doi:10.15252/embj.2018100785 · Cited by 73
Avram, S., Halip, L., Curpan, R., & Oprea, T. I. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00052-w · Cited by 17
Avram, S., Halip, L., Curpan, R., & Oprea, T. I. (2021) · Nature Reviews Drug Discovery · doi:10.1038/d41573-021-00057-z · Cited by 13 · cited 1×
“Among the novel drugs with new mechanism of action reported for 2020, SLCs feature prominently (Avram et al., 2021).”
Background
Cited by
Khan, A., Unlu, G., Lin, P., Liu, Y., Kilic, E., Kenny, T. C., Birsoy, K., & Gamazon, E. R. (2024) · Nature Genetics · doi:10.1038/s41588-024-01827-2 · Cited by 29
Illuminating the function of the orphan transporter, SLC22A10, in humans and other primates
Yee, S. W., Ferrández-Peral, L., Alentorn-Moron, P., Fontsere, C., Ceylan, M., Koleske, M. L., Handin, N., Artegoitia, V. M., Lara, G., Chien, H.-C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48569-7 · Cited by 4
Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
Giacomini, K., Yee, S. W., Ferrández-Peral, L., Alentorn, P., Fontsere, C., Ceylan, M., Koleske, M., Handin, N., Artegoitia, V., Lara, G., et al. (2023) · doi:10.21203/rs.3.rs-3263845/v1 · Cited by 1
Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
(2023) · doi:10.1101/2023.08.08.552553
Metadata
- Authors
- Dvorak, V., Wiedmer, T., Ingles-Prieto, A., Altermatt, P., Batoulis, H., Bärenz, F., Bender, E., Digles, D., Dürrenberger, F., Heitman, L. H., IJzerman, A. P., Kell, D. B., Kickinger, S., Körzö, D., Leippe, P., Licher, T., Manolova, V., Rizzetto, R., Sassone, F., Scarabottolo, L., Schlessinger, A., Schneider, V., Sijben, H. J., Steck, A.-L., Sundström, H., Tremolada, S., Wilhelm, M., Wright Muelas, M., Zindel, D., Steppan, C. M., & Superti-Furga, G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2021-08-10
- Volume
- 12
- Pages
- 722889-722889
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3194299440
- Cited by
- 67
- References
- 28
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.